We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Empagliflozin

Australian Public Assessment Report

AusPAR

AusPAR: Empagliflozin [PDF, 1.07 MB]

AusPAR: Empagliflozin [Word, 1.13 MB]

Attachment: Product information: Empagliflozin [PDF, 309.27 KB]

Attachment: Product information: Empagliflozin [Word, 106.64 KB]

Attachment: Extract from the Clinical Evaluation Report: Empagliflozin [PDF, 1.67 MB]

Attachment: Extract from the Clinical Evaluation Report: Empagliflozin [Word, 2 MB]

Device/Product Name

Jardiance

Active ingredients

Empagliflozin

AusPAR Date

27 January 2015

Published

15 March 2015

Submission Number

PM-2013-00674-1-5

Submission Type

New chemical entity

Decision

Approved